The global HAIs (hospital-acquired infections) control market is experiencing significant growth due to the high prevalence of several hospital infections
and increasing aging population. According to WHO, in high-income nations around 30% of the patients in ICU gets affected with at least one kind of HAI,
while in low and middle income nations this frequency was at least 2 to 3 times higher.
Hospital-acquired infections (HAIs) are nosocomial infections which are acquired by patients during their stay in hospitals. These infections are caused
due to the transmission of pathogens from one patient to another. Hospital-acquired infections can also be caused as a result of transmission of pathogens
from a healthcare worker to a patient. The most common causes of HAIs are lack of awareness about pathogen transmission among the hospital staff as a
result of limited training and poor infection control practices in hospitals and sometimes the absence of proper hospital infrastructure.
High Prevalence of HAIs Driving the Market Growth
According to a market research firm, the global HAIs control market will grow
at a modest CAGR of 8.5% during the forecast period from 2014 to 2020. In 2014, the global HAIs control market was valued at US$50,807.0 million and will
reach an estimated value of US$82,889.4 million by 2020.
Apart from the high prevalence of numerous hospital infections, the hot and humid environmental conditions in hospitals will also result in higher
hospital-acquired infections. Furthermore, the technology trend of accelerating popularity of gas plasma sterilization technology will drive the global
HAIs control market. Players in the market will also benefit from the new product launches and the growing number of M&As. Nevertheless, the global
HAIs control market will be suppressed by the increasing number of multi-drug resistant pathogens.
STERIS Corp. and Getinge AB Leading the HAIs Control Market
The leading company in the global HAIs control market is STERIS Corporation. This company is leading the overall HAIs control market on the basis of
cleaning and sterilization. In 2013, STERIS Corporation held a market share of 25% in global HAIs control market in sterilization and cleaning. Another
major player in the market is Getinge AB, which held a market share of 24% in the global HAIs control market for cleaning and sterilization for HAIs
control in 2013. Other prominent players in the global HAIs control market are Cepheid, Becton, Pfizer, Hoffmann-La Roche, Advanced Sterilization Products
Division Ethicon US, Kimberly-Clark, LLC, and Dickinson and Company.
Diagnostic Technique Sector Dominating the Global HAIs Control Market
The global HAIs control market according to type is segmented into cleaning and sterilization, treatment, and diagnostic techniques. Diagnostic techniques
sector currently is the largest segment in the overall HAIs control market. The segment of diagnostic techniques in the global HAIs control market is
divided into manual testing, confirmation testing, and automated testing. On the other hand, pneumonia is one of the primary diseases causing HAI, which
makes it the largest segment in terms of diseases. The cleaning and sterilization HAIs control market is classified into disinfection of linen, instrument
sterilization, wide-area sterilization. According to treatment, the global HAIs control market is categorized into pharmaceutical treatment and
Geography-wise, the global HAIs control market is segmented into Europe, North America, and Asia. Presently, North America holds the largest market share
in the global HAIs control market, as this region has improved healthcare facilities. In 2014, the North America HAIs control market was estimated at
US$21,319.2 million with an 8.3% CAGR during the forecast period will reach a value of US$34,430.3 million by 2020.
On the other hand, Asia Pacific due to the growing prevalence of HAIs cases, will emerge as the fastest growing regional market during the forecast period.
Browse the full Global HAIs Control Market report at http://www.mrrse.com/hospital-acquired-infection-control-market